Does tesamorelin cause hair loss? Clinical trials have not linked the drug to hair loss, but hormones, genetics, and other factors can play a role.
Tesamorelin has not been shown to cause hair loss in published clinical trials, and hair loss does not appear among the common side effects in its FDA-approved labeling. Most shedding reported by people using the drug is more likely tied to genetics, thyroid problems, nutrient gaps, stress, or other medications. Tesamorelin does change growth hormone and IGF-1 signaling, so it is reasonable to track any changes and talk with a healthcare provider about them.
What Tesamorelin Is and How It Works
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog sold under the brand name Egrifta. The FDA approved it for one specific use: reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
Rather than delivering growth hormone directly, tesamorelin signals the pituitary gland to release more of the body's own growth hormone. That raises growth hormone and IGF-1 levels, but usually in a more pulsatile pattern than injectable HGH produces. Many people who research tesamorelin also want to know does hgh cause hair loss, since both pathways ultimately influence growth hormone and IGF-1.
Tesamorelin is a prescription medication in the United States and is not approved for general weight loss, bodybuilding, or anti-aging use.
What the Clinical Trials Actually Report
The best safety data on tesamorelin comes from randomized trials in patients with HIV-associated lipodystrophy, plus post-marketing reports collected since approval. In those studies, the most frequently reported complaints involved the injection site, joints, muscles, and fluid retention.
| Side effect | How often it is reported |
|---|---|
| Injection site reactions (pain, redness, irritation) | Common |
| Joint pain (arthralgia) | Common |
| Muscle pain (myalgia) | Common |
| Swelling in the hands, feet, or legs | Common |
| Nausea | Occasional |
| Elevated IGF-1 levels | Monitored during treatment |
| Hair loss | Not a commonly reported event |
Hair loss does not appear as a common adverse event in the trial data or in the approved product label. That does not prove the drug can never be involved in shedding, but it does mean hair loss is not a recognized, typical reaction to tesamorelin.
Is There a Biological Reason Tesamorelin Could Affect Hair?
Growth hormone and IGF-1 do influence hair follicles, so the question is not unreasonable. In laboratory and animal research, IGF-1 has generally been associated with follicle growth and elongation rather than shedding.
Growth hormone deficiency, meanwhile, has been linked to dry, brittle hair and thinning in some patients. That evidence points in the opposite direction from a hair-loss risk: low growth hormone states are more often connected to hair changes than elevated ones.
Where hormonal hair loss usually comes from
- Androgens: DHT drives male and female pattern hair loss in genetically susceptible people.
- Thyroid dysfunction: Both an overactive and underactive thyroid can trigger diffuse shedding.
- Telogen effluvium: Surgery, illness, crash dieting, or major stress can push follicles into a resting phase.
- Nutrient shortfalls: Low iron, ferritin, zinc, vitamin D, and protein intake are common contributors.
- Other medications: Certain acne, blood pressure, antidepressant, and weight loss drugs carry hair-loss reports.
How Tesamorelin Compares With Other Weight and Peptide Drugs
Hair-shedding questions come up across this entire category of medications, and the answers are not identical. The table below summarizes what is generally reported for each option.
| Compound | Hair-loss reports | Context |
|---|---|---|
| Tesamorelin | Rare; not listed in labeling | GHRH analog approved for HIV-associated lipodystrophy |
| Injectable HGH | Rare; mostly case reports | Produces higher IGF-1 exposure than GHRH analogs |
| Semaglutide | Reported, often with rapid weight loss | Frequently linked to telogen effluvium and low protein intake |
| Tirzepatide | Reported, similar pattern | Fast fat loss combined with reduced food intake |
| Selank | Very limited data | No reliable human hair-loss data available |
| BPC-157 | Very limited data | Not FDA-approved for human use |
Because rapid weight loss itself can trigger shedding, people researching GLP-1 drugs often ask can semaglutide cause hair loss, and the answer usually points to the speed of the weight loss and nutrient intake rather than the molecule. Users also search can tirzepatide cause hair loss for the same reason, and the pattern of reports looks similar.
Tesamorelin works differently. Its approved effect targets visceral fat rather than producing the rapid, total-body weight loss seen with GLP-1 medications. People exploring metabolic peptides sometimes ask does bpc-157 help with weight loss, but the human evidence for that is thin and the compound is not approved for human use in the United States.
Other Tesamorelin Side Effects Worth Knowing
Digestive complaints show up in the tesamorelin literature, which is why some users ask does tesamorelin cause diarrhea. Nausea and loose stools are generally mild and often improve as the body adjusts, but persistent symptoms should be reported to a prescriber.
Other side effects that carry more clinical weight include fluid retention, joint and muscle pain, carpal tunnel symptoms, and rising IGF-1 levels. Providers typically monitor IGF-1 during treatment and adjust or stop therapy if levels climb too high.
What to Do If You Notice Shedding
If you are using tesamorelin and notice more hair in the shower or on your pillow, treat it as a medical question rather than a cosmetic one.
- Note when the shedding started and how long it has lasted.
- Ask your prescriber for lab work, including thyroid function, iron, ferritin, and vitamin D.
- Review every medication and supplement you take, including over-the-counter products.
- Do not stop a prescribed medication on your own; talk with your provider first.
- Consider a dermatology referral if shedding continues beyond a few months.
Tesamorelin is not FDA-approved for human use outside of HIV-associated lipodystrophy, and compounded or gray-market versions may contain different ingredients or doses than the approved product. Anyone considering tesamorelin should speak with a licensed healthcare professional about benefits, risks, and monitoring.
Frequently Asked Questions
Does tesamorelin cause hair loss?
There is no strong evidence that tesamorelin causes hair loss. Hair loss is not listed as a common side effect in the clinical trial data or in the FDA-approved labeling for tesamorelin, and reported shedding among users is more often explained by genetics, thyroid issues, nutrient deficiencies, or stress.
Could tesamorelin make existing pattern hair loss worse?
Tesamorelin raises growth hormone and IGF-1, and IGF-1 is generally associated with follicle growth rather than shedding in laboratory research. Androgenetic alopecia is driven mainly by genetics and DHT, not by GHRH analogs, so the drug is unlikely to accelerate pattern baldness on its own. Any noticeable change in shedding is still worth discussing with a doctor.
What are the most common side effects of tesamorelin?
The most frequently reported side effects are injection site reactions, joint pain, muscle pain, and swelling from fluid retention. Nausea and digestive upset such as diarrhea are also reported. Elevated IGF-1 levels are monitored by prescribers during treatment.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.